Find Clinical Trial

Evaluation of the clinical efficacy and safety of perindopril 10 mg/indapamide 2.5 mg/amlodipine 5 or 10 mg/bisoprolol 5 mg in single-pill combination after 8 weeks of treatment versus the free combination of perindopril 10 mg, indapamide 2.5 mg and amlodipine 5 or 10 mg in patients with uncontrolled essential hypertension. An international, multicentre, randomised, double-blind, 16-week study.


← Back
Study Phase

Phase 3

Therapeutic Area

Cardiovascular Diseases

IndicationHypertension
SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active substance/
Medical device

AMLODIPINE BESILATE, BISOPROLOL FUMARATE, INDAPAMIDE, PERINDOPRIL ARGININE,
S005179

Active Substance CodeS005179
Protocol CodeCL3-05179-002
EudraCT Code2020-004891-16


Documents and links

Results are not yet available.




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility